NASDAQ:MGTX

MeiraGTx (MGTX) Stock Forecast, Price & News

$7.19

+0.30 (+4.35%)

(As of 01:39 PM ET)

Compare

Today's Range: $6.98
▼
$7.19
50-Day Range: $5.04
▼
$7.70
52-Week Range: $4.77
▼
$11.57

Volume: 28,176 shs
Average Volume: 148,240 shs
Market Capitalization: $427.81 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $29.33

MeiraGTx MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 313.7% Upside
$29.33 Price Target
Short Interest: Healthy
3.15% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.54
Upright™ Environmental Score
News Sentiment: 0.73
Based on 2 Articles This Week
Insider Trading: Acquiring Shares
$25 M Bought Last Quarter
Proj. Earnings Growth: Growing
From ($2.43) to ($1.93) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.66 out of 5 stars

Medical Sector

81st out of 983 stocks

Biological Products, Except Diagnostic Industry

13th out of 164 stocks

3.5

Analyst's Opinion

Consensus Rating
MeiraGTx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $29.33, MeiraGTx has a forecasted upside of 313.7% from its current price of $7.09.
Amount of Analyst Coverage
MeiraGTx has only been the subject of 2 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
3.15% of the float of MeiraGTx has been sold short.
Short Interest Ratio / Days to Cover
MeiraGTx has a short interest ratio ("days to cover") of 8.
Change versus previous month
Short interest in MeiraGTx has recently decreased by 3.15%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
MeiraGTx does not currently pay a dividend.
Dividend Growth
MeiraGTx does not have a long track record of dividend growth.

4.8

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
MeiraGTx has received a 78.28% net impact score from Upright. The largest positive contribution comes from its "Creating knowledge" impact, which is false driven by its "Preclinical research services for physical health", "Clinical research services for physiological diseases ", and "Basic medical research services" products. See details.
Environmental Sustainability
The Environmental Impact score for MeiraGTx is -0.54.

3.7

News and Social Media Coverage

News Sentiment
MeiraGTx has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for MeiraGTx this week, compared to 1 article on an average week.
Search Interest
7 people have searched for MGTX on MarketBeat in the last 30 days.
MarketBeat Follows
3 people have added MeiraGTx to their MarketBeat watchlist in the last 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, MeiraGTx insiders have bought more of their company's stock than they have sold. Specifically, they have bought $25,000,000.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 9.90% of the stock of MeiraGTx is held by insiders.
Percentage Held by Institutions
70.10% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for MeiraGTx are expected to grow in the coming year, from ($2.43) to ($1.93) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of MeiraGTx is -2.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of MeiraGTx is -2.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
MeiraGTx has a P/B Ratio of 4.66. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About MeiraGTx (NASDAQ:MGTX) Stock

MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. The company was founded on March 20, 2015 and is headquartered in New York, NY.

Receive MGTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter.

MGTX Stock News Headlines

May 18, 2023 | americanbankingnews.com

MeiraGTx Holdings plc (NASDAQ:MGTX) Director Perceptive Advisors Llc Purchases 4,347,826 Shares

May 17, 2023 | msn.com

Wall Street Analysts Predict a 314.29% Upside in MeiraGTx Holdings PLC (MGTX): Here's What You Should Know

June 2, 2023 | Edge On The Street (Ad)

Is Graphite the New Lithium?

Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.

May 17, 2023 | finance.yahoo.com

Wall Street Analysts Predict a 314.29% Upside in MeiraGTx Holdings PLC (MGTX): Here's What You Should Know

May 16, 2023 | finance.yahoo.com

MeiraGTx Announces the Presentation of Nine Posters at the American Society of Gene and Cell Therapy (ASGCT) 2023 Annual Meeting

May 15, 2023 | americanbankingnews.com

MeiraGTx (NASDAQ:MGTX) Price Target Lowered to $25.00 at Piper Sandler

May 13, 2023 | msn.com

MeiraGTx Hldgs: Q1 Earnings Insights

May 13, 2023 | markets.businessinsider.com

Piper Sandler Keeps Their Buy Rating on Meiragtx Holdings (MGTX)

June 2, 2023 | Edge On The Street (Ad)

The Graphite Shortage Story You're Not Being Told

Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.

May 13, 2023 | msn.com

Piper Sandler Maintains MeiraGTx Holdings (MGTX) Overweight Recommendation

May 11, 2023 | finance.yahoo.com

MeiraGTx Reports First Quarter 2023 Financial and Operational Results

May 10, 2023 | americanbankingnews.com

Financial Comparison: Coherus BioSciences (NASDAQ:CHRS) and MeiraGTx (NASDAQ:MGTX)

May 3, 2023 | finance.yahoo.com

MeiraGTx Announces $60 Million Private Placement of Ordinary Shares

April 21, 2023 | finance.yahoo.com

MeiraGTx Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting

April 21, 2023 | americanbankingnews.com

MeiraGTx Holdings plc (NASDAQ:MGTX) Sees Large Increase in Short Interest

April 12, 2023 | finance.yahoo.com

MeiraGTx Holdings plc (NASDAQ:MGTX) has caught the attention of institutional investors who hold a sizeable 31% stake

April 8, 2023 | markets.businessinsider.com

Meiragtx Holdings (MGTX) Gets a Buy from RBC Capital

March 16, 2023 | finance.yahoo.com

A Look At The Intrinsic Value Of MeiraGTx Holdings plc (NASDAQ:MGTX)

January 29, 2023 | forbes.com

Meiragtx Holdings

December 13, 2022 | finance.yahoo.com

MeiraGTx Holdings (NASDAQ:MGTX) investors are sitting on a loss of 71% if they invested three years ago

December 8, 2022 | finance.yahoo.com

MeiraGTx to Present Clinical Data from Phase 1 Trial of AAV-hAQP1 for Radiation-Induced Xerostomia on Tuesday, December 13, 2022

November 16, 2022 | finance.yahoo.com

MeiraGTx Holdings Third Quarter 2022 Earnings: Misses Expectations

November 11, 2022 | finance.yahoo.com

Time To Worry? Analysts Are Downgrading Their MeiraGTx Holdings plc (NASDAQ:MGTX) Outlook

November 10, 2022 | finance.yahoo.com

MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Misses Revenue Estimates

November 3, 2022 | finance.yahoo.com

Institutional investors own a significant stake of 35% in MeiraGTx Holdings plc (NASDAQ:MGTX)

October 11, 2022 | businesswire.com

Flatiron Health Expands Leadership Team with Two New Executive Hires - Business Wire

October 4, 2022 | globenewswire.com

MeiraGTx Announces the Upcoming Presentation of 15 Abstracts at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress - GlobeNewswire

See More Headlines

MGTX Price History

30 days | 90 days | 365 days | Advanced Chart

MGTX Company Calendar

Last Earnings: 3/14/2023
Today: 6/02/2023
Next Earnings (Estimated): 8/10/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:MGTX
CUSIP: N/A
CIK: 1735438
Web: www.meiragtx.com
Phone: (646) 860-7985
Fax: N/A
Employees: 287
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $29.33
High Stock Price Forecast: $41.00
Low Stock Price Forecast: $22.00
Forecasted Upside/Downside: +325.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.79)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-129,620,000.00
Net Margins: -265.59%
Pretax Margin: -946.58%
Return on Equity: -109.13%
Return on Assets: -44.45%

Debt

Debt-to-Equity Ratio: 0.97
Current Ratio: 1.50
Quick Ratio: 1.50

Sales & Book Value

Annual Sales: $15.92 million
Price / Sales: 25.75
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.52 per share
Price / Book: 4.53

Miscellaneous

Outstanding Shares: 59,500,000
Free Float: 53,610,000
Market Cap: $409.96 million
Optionable: Not Optionable
Beta: 1.37

Key Executives

Alexandria Forbes
President, Chief Executive Officer & Director

Richard Giroux
Chief Operating & Financial Officer

Robert K. Zeldin
Chief Medical Officer

Stuart Naylor
Chief Development Officer

Tim Randall
Senior Vice President-Risk & Internal Controls

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MGTX Stock - Frequently Asked Questions

Should I buy or sell MeiraGTx stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MeiraGTx in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MGTX shares.
View MGTX analyst ratings or view top-rated stocks.
What is MeiraGTx's stock price forecast for 2023?: 2 Wall Street research analysts have issued 12-month target prices for MeiraGTx's shares. Their MGTX share price forecasts range from $22.00 to $41.00. On average, they anticipate the company's stock price to reach $29.33 in the next year. This suggests a possible upside of 325.7% from the stock's current price.
View analysts price targets for MGTX or view top-rated stocks among Wall Street analysts.
How have MGTX shares performed in 2023?: MeiraGTx's stock was trading at $6.52 at the start of the year. Since then, MGTX stock has increased by 5.7% and is now trading at $6.89.
View the best growth stocks for 2023 here.
When is MeiraGTx's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our MGTX earnings forecast.
How were MeiraGTx's earnings last quarter?: MeiraGTx Holdings plc (NASDAQ:MGTX) issued its quarterly earnings data on Tuesday, March, 14th. The company reported ($0.58) earnings per share (EPS) for the quarter. The company earned ($5.29) million during the quarter, compared to analyst estimates of $8.57 million. MeiraGTx had a negative net margin of 265.59% and a negative trailing twelve-month return on equity of 109.13%.
What other stocks do shareholders of MeiraGTx own?: Based on aggregate information from My MarketBeat watchlists, some companies that other MeiraGTx investors own include AbbVie (ABBV), Sorrento Therapeutics (SRNE), Aldeyra Therapeutics (ALDX), Inovio Pharmaceuticals (INO), Kadmon (KDMN), Pfizer (PFE), VBI Vaccines (VBIV), Novavax (NVAX), Viking Therapeutics (VKTX) and Advanced Micro Devices (AMD).

When did MeiraGTx IPO?: (MGTX) raised $75 million in an initial public offering (IPO) on Friday, June 8th 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI served as the underwriters for the IPO and Chardan was co-manager.
What is MeiraGTx's stock symbol?: MeiraGTx trades on the NASDAQ under the ticker symbol "MGTX."
Who are MeiraGTx's major shareholders?: MeiraGTx's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (4.36%), Prosight Management LP (3.06%), Royce & Associates LP (1.14%), Rhenman & Partners Asset Management AB (1.11%), State Street Corp (0.83%) and Dimensional Fund Advisors LP (0.87%). Insiders that own company stock include Alexandria Forbes, Elizabeth A Cook, Joel S Marcus, Perceptive Advisors Llc, Richard Giroux, Robert J Wollin, Robert K Zeldin, Stuart Naylor and Thomas E Shenk.
View institutional ownership trends.
How do I buy shares of MeiraGTx?: Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is MeiraGTx's stock price today?: One share of MGTX stock can currently be purchased for approximately $6.89.
How much money does MeiraGTx make?: MeiraGTx (NASDAQ:MGTX) has a market capitalization of $409.96 million and generates $15.92 million in revenue each year. The company earns $-129,620,000.00 in net income (profit) each year or ($2.79) on an earnings per share basis.
How many employees does MeiraGTx have?: The company employs 287 workers across the globe.
How can I contact MeiraGTx?: MeiraGTx's mailing address is 450 East 29thStreet 14thFloor, NEW YORK NY, 10016. The official website for the company is www.meiragtx.com. The company can be reached via phone at (646) 860-7985 or via email at investors@meiragtx.com.

This page (NASDAQ:MGTX) was last updated on 6/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial